Our history
Life Medical Control was founded in 2007 by a team of cardiologists from Saint-Etienne University Hospital and engineers.
Already heavily involved in research, the wish was to be able to go further and provide concrete solutions.
Today the company continues with its roots in research and markets a medical device called NeuroCoach.
The latter brings together our scientific and technical expertise since it combines our know-how in electronics, IT and medical matters. The NeuroCoach solution integrates detection algorithms that we have developed as well as technology integrated into the device manufactured in France.
Before our creation, our origins
Life Medical Control is a university company created to follow up on the work of the team of researchers at Saint-Étienne University Hospital on the ANS (Autonomous Nervous System) since 1995. Made up of medical researchers and industrialists, Life Medical Control has developed the equipment as well as the associated services making it possible to determine the quality of the ANS. So in 2007, this work led to the creation of Life Medical Control.
Our birth
Our company was therefore founded in 2007, initially with a focus on the analysis of the autonomic nervous system. This line of work will lead us to develop a first version of NeuroCoach. Life Medical Control sees the excitement of work between the scientific part and the electronic development part which opens up new perspectives.
The ANS era
During this period we focused on improving our SNA calculation, analysis and measurement methods. It was also during this period that we had the opportunity to follow and support the French XV during the World Cup in New Zealand in 2011.
New turning point
Following this experience we refocused our activity on the monitoring and analysis of the ANS for the purposes of pathology prediction. By combining our different learnings from past years, we have enriched our proposal. We then integrated the detection of cardiac events, sleep apnea risks and ANS analysis into our NeuroCoach recorder.
Moving towards prevention, an obvious fact
Thanks to our years of research, we have gradually implemented a powerful screening tool for vascular risk factors that can prove very useful in the primary and secondary prevention of Stroke.
Stroke represents 150,000 victims each year in France, and twice as many by 2050. Faced with these findings, we cannot remain without action. This is why we encourage research through the publication of papers concerning atrial fibrillation, the autonomic nervous system, sleep apnea or even the benefit of physical activity or prevention.
